Zobrazeno 1 - 10
of 15
pro vyhledávání: '"Marcia, Llacuachaqui"'
Autor:
Judith Hurley, Raleigh Butler, Sara Panahi, John Lunn, Marcia Llacuachaqui, Du Vaughan Curling, Steven A. Narod, Talia Donenberg, Catherine Ho, Mohammad R. Akbari, David Bobrowski
Publikováno v:
Molecular Genetics & Genomic Medicine
Purpose We sought to determine to what extent the knowledge of carrying a BRCA1 or BRCA2 mutation influences the uptake of preventive surgeries in Bahamian women, including bilateral salpingo‐oophorectomy and bilateral mastectomy. Patients and meth
Publikováno v:
Journal of Dental Education. 80:301-310
Persons with disabilities (PWDs) have a disproportionate level of dental disease relative to the general population. Access to care is a cause along with dentists' willingness to treat PWDs. The aim of this study was to investigate the expectations a
Publikováno v:
Journal of dental education. 80(3)
Persons with disabilities (PWDs) have a disproportionate level of dental disease relative to the general population. Access to care is a cause along with dentists' willingness to treat PWDs. The aim of this study was to investigate the expectations a
Autor:
Nida Mian, Marcia Llacuachaqui, Kevin S. Hughes, Aletta Poll, Ping Sun, Steven A. Narod, Melissa Enmore, Sonia Nanda, Kelly A. Metcalfe
Publikováno v:
Breast Cancer Research and Treatment. 133:735-740
There are two mutations in BRCA1 and one in BRCA2, which are present in up to 2.5% of Jewish women. Population genetic testing for Jewish women has been proposed; however, it is unclear how this would impact the uptake of cancer prevention options an
Autor:
N Mian, Aletta Poll, Sonia Nanda, Steven A. Narod, Kelly A. Metcalfe, Ping Sun, Marcia Llacuachaqui, A Tulman
Publikováno v:
Clinical Genetics. 78:411-417
It is not known to what extent participation in a genetic testing program for BRCA1 and BRCA2, which does not include an extensive pre-test counselling session, influences cancer-related distress, cancer risk perception and patient satisfaction. Unse
Autor:
Robert Royer, Jeffrey N. Weitzel, Maria Cristina Magallanes-Hoyos, D. Castillo, J. Herzog, Cynthia Villarreal-Garza, Rosa María Álvarez-Gómez, Marcia Llacuachaqui, Luis A. Herrera, Lenny Gallardo, Erika Sifuentes, Fernando Lara-Medina, Alejandro Mohar, Mohammad R. Akbari, Steven A. Narod
Publikováno v:
Breast cancer research and treatment. 150(2)
Various guidelines recommend that women with triple-negative breast cancer should be tested for BRCA1 mutations, but the prevalence of mutations may vary with ethnic group and with geographic region, and the optimal cutoff age for testing has not bee
Autor:
Dina Nikitina, Marcia Llacuachaqui, Joanne Kotsopoulos, Daniel W. Sepkovic, H. Leon Bradlow, Steven A. Narod
Publikováno v:
Familial cancer. 14(2)
Hormonal exposures are known to influence breast cancer risk among women with a BRCA1 mutation. Thus, dietary factors that increase the 2-hydroxyestrone (OHE):16α-OHE ratio, a biomarker inversely related to breast cancer development, may also influe
Autor:
Gabriela Torres-Mejía, Elad Ziv, Carolina Ortega-Olvera, Robert Royer, Eduardo Lazcano-Ponce, Marcia Llacuachaqui, Louis Martínez-Matsushita, Steven A. Narod, Mohammad R. Akbari, Catherine M. Phelan, Angélica Ángeles-Llerenas, Anna R. Giuliano
Publikováno v:
Cancer epidemiology, biomarkersprevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology. 24(3)
Background: Germline mutations in the BRCA1 and BRCA2 genes confer an estimated 58% to 80% lifetime risk of breast cancer. In general, screening is done for cancer patients if a relative has been diagnosed with breast or ovarian cancer. There are few
Autor:
Kelly A. Metcalfe, Marcia Llacuachaqui, Robert Royer, Aletta Poll, Sonia Nanda, Steven A. Narod, Ping Sun
Publikováno v:
British Journal of Cancer
Background: Guidelines for genetic testing for BRCA1 or BRCA2 stipulate that a personal or family history of cancer is necessary to be eligible for testing. Approximately 2% of Ashkenazi Jewish women carry a mutation, but to date population-based tes
Autor:
Steven A. Narod, S Li, Alma Ortiz, M Aguilar Herrera, L García-Jiménez, Marcia Llacuachaqui, Robert Royer, K Loáiciga Vega, Gutiérrez Espeleta
Publikováno v:
Clinical genetics. 82(5)
The contribution of mutations in BRCA1 and BRCA2 genes to the burden of breast cancer in Costa Rica has not been studied. We estimated the frequency of BRCA mutations among 111 Costa Rican women with breast cancer and a family history of breast cance